Loading...
Loading...
Of the 14 tracked institutions holding GMED, 7 have a 3-year clone track record — 5 of them beat the S&P. Average holder's clone alpha: +3.2pt. It's a gauge of who owns the name, not just how many.
Among the 14 tracked institutional investors we monitor, GMED (GLOBUS MED INC) is held with a combined value of $2.70B across 31,240,556 shares. The largest holder is VANGUARD GROUP INC with a position worth $921.07M (0.01% of their portfolio). MAVERICK CAPITAL LTD opened a new position in the most recent quarter. 9 funds increased their holdings. 4 funds reduced their position.
Total Institutional Value
$2.70B
Total Shares Held
31,240,556
Institutional Holders
14
% of Shares Outstanding
23.0%
of 135.74M shares · SEC 2026-05-05
Days to Cover
3.6+35.5%
7.41M shares short · FINRA 2026-06-30
Tracked 13F institutions hold 23.0% of GMED's shares outstanding. This is a floor: 13F filings arrive on a ~45-day lag and we track only a subset of institutional filers, so true institutional ownership is higher. Shares-outstanding is the latest SEC cover-page figure (as of 2026-05-05), not a live float.
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $921.07M | 0.01% | -0.5% |
| 2 | BlackRock, Inc. | $904.46M | 0.02% | +2.1% |
| 3 | STATE STREET CORP | $309.35M | 0.01% | +3.7% |
| 4 | CITADEL ADVISORS LLC | $169.40M | 0.12% | -22.6% |
| 5 | MILLENNIUM MANAGEMENT LLC | $141.59M | 0.06% | +232.4% |
| 6 | AQR CAPITAL MANAGEMENT LLC | $72.06M | 0.03% | +617.1% |
| 7 | FMR LLC | $51.74M | 0.00% | +1121.3% |
| 8 | PRICE T ROWE ASSOCIATES INC /MD/ | $51.71M | 0.01% | -13.8% |
| 9 | Grantham, Mayo, Van Otterloo & Co. LLC | $34.61M | 0.09% | -4.4% |
| 10 | Bridgewater Associates, LP | $28.47M | 0.13% | +16.3% |
| Member | Type | Date |
|---|---|---|
| Lisa McClain | Sell | Jul 10, 2025 |
| Lisa McClain | Sell | Jun 24, 2025 |
| Lisa McClain | Buy | Jun 17, 2025 |
| Josh Gottheimer | Sell |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of GMED with a position worth $921.07M, representing 0.01% of their portfolio. In total, 14 institutional investors hold GMED with a combined value of $2.70B.
In the most recent quarter, 1 fund opened a new position in GMED. Additionally, 9 increased their holdings and 4 reduced their positions.
Institutional investors hold $2.70B worth of GMED stock across 14 positions. The largest institutional holder is VANGUARD GROUP INC with $921.07M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For GMED, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their GMED positions.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
| Apr 9, 2025 |
| Thomas R Tillis | Sell | Feb 13, 2015 |
Last Close
$76.49
2026-07-24
YTD
-12.4%
55% of 52-week range
